Santen Pharmaceutical Co., Ltd. (SNPHY)
11.78
-0.07
(-0.59%)
USD |
OTCM |
Aug 24, 16:00
Santen Pharmaceutical Total Assets (Quarterly) : 2.559B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.559B |
| March 31, 2026 | 2.659B |
| December 31, 2025 | 2.559B |
| September 30, 2025 | 2.635B |
| June 30, 2025 | 2.825B |
| March 31, 2025 | 2.737B |
| December 31, 2024 | 2.534B |
| September 30, 2024 | 2.860B |
| June 30, 2024 | 2.699B |
| March 31, 2024 | 2.879B |
| December 31, 2023 | 3.035B |
| September 30, 2023 | 2.861B |
| June 30, 2023 | 2.882B |
| March 31, 2023 | 3.165B |
| December 31, 2022 | 3.184B |
| September 30, 2022 | 2.947B |
| June 30, 2022 | 3.395B |
| March 31, 2022 | 3.790B |
| December 31, 2021 | 3.731B |
| September 30, 2021 | 3.768B |
| June 30, 2021 | 3.578B |
| March 31, 2021 | 3.668B |
| December 31, 2020 | 4.001B |
| September 30, 2020 | 3.980B |
| June 30, 2020 | 3.797B |
| Date | Value |
|---|---|
| March 31, 2020 | 3.786B |
| December 31, 2019 | 3.752B |
| September 30, 2019 | 3.674B |
| June 30, 2019 | 3.586B |
| March 31, 2019 | 3.534B |
| December 31, 2018 | 3.539B |
| September 30, 2018 | 3.522B |
| June 30, 2018 | 3.416B |
| March 31, 2018 | 3.653B |
| December 31, 2017 | 3.359B |
| September 30, 2017 | 3.324B |
| June 30, 2017 | 2.898B |
| March 31, 2017 | 3.221B |
| December 31, 2016 | 2.754B |
| September 30, 2016 | 3.195B |
| June 30, 2016 | 3.205B |
| March 31, 2016 | 3.162B |
| December 31, 2015 | 2.990B |
| September 30, 2015 | 2.940B |
| June 30, 2015 | 2.463B |
| March 31, 2015 | 2.471B |
| December 31, 2014 | 2.319B |
| September 30, 2014 | 2.386B |
| June 30, 2014 | 2.532B |
| March 31, 2014 | 2.244B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 96.37B |
| Daiichi Sankyo Co., Ltd. | 25.32B |
| Eisai Co., Ltd. | 9.587B |
| Chugai Pharmaceutical Co., Ltd. | 15.07B |
| Ono Pharmaceutical Co., Ltd. | 6.672B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 717.30M |
| Shareholders Equity (Quarterly) | 1.847B |
| Debt to Equity Ratio | 0.1033 |
| Current Ratio | 2.816 |
| Net Debt Paydown Yield | 0.18% |